Perrigo Company PLC
PRGO21.190USD
-0.060-0.28%
收盘 10/13, 16:00（美东）报价延迟15分钟
2.92B总市值
亏损市盈率 TTM
关于 Perrigo Company PLC 公司
Perrigo Company plc 是一家非处方 (OTC) 健康和保健解决方案提供商，旨在提高个人健康水平。其部门包括消费者自我护理美洲 (CSCA) 和消费者自我护理国际 (CSCI)。CSCA 部门包括其在美国和加拿大的消费者自我护理业务。它主要为客户提供以客户自有品牌和/或独家品牌销售和营销的自我护理产品。CSCI 部门包括其在美国和加拿大以外的消费者自我护理业务，主要是在欧洲和澳大利亚。这些产品由公司开发、制造、营销和分销。其产品类别包括上呼吸道、疼痛和助眠剂、护肤和个人卫生、消化健康和营养。其主要品牌产品以 Compeed、Dr. Fresh、Firefly、Good Sense、Mederma、Nasonex、Solpadeine、Coldrex 和 Physiomer 等品牌销售。
Perrigo Company PLC简介
公司代码PRGO
公司名称Perrigo Company PLC
上市日期Dec 17, 1991
CEOMr. Patrick Lockwood-Taylor
员工数量8379
证券类型Ordinary Share
年结日Dec 17
公司地址The Sharp Building
城市DUBLIN
上市交易所NYSE Consolidated
国家Ireland
邮编D02 TY74
电话3532696738451
网址https://www.perrigo.com/
公司代码PRGO
上市日期Dec 17, 1991
CEOMr. Patrick Lockwood-Taylor
Perrigo Company PLC公司高管
名称
名称/职务
职务
持股
持股变动
Mr. Patrick Lockwood-Taylor
Mr. Patrick Lockwood-Taylor
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
85.81K
+5.48%
Mr. Geoffrey M. (Geoff) Parker
Mr. Geoffrey M. (Geoff) Parker
Independent Director
Independent Director
60.29K
+16.75%
Mr. Eduardo Guarita Bezerra
Mr. Eduardo Guarita Bezerra
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
48.95K
+6.53%
Mr. Robert Willis
Mr. Robert Willis
Chief Human Resources Officer, Executive Vice President
Chief Human Resources Officer, Executive Vice President
41.94K
+3.68%
Mr. Bradley A. (Brad) Alford
Mr. Bradley A. (Brad) Alford
Independent Director
Independent Director
41.16K
+14.30%
Mr. Donal O'Connor
Mr. Donal O'Connor
Independent Director
Independent Director
31.84K
+19.30%
Ms. Adriana (Andi) Karaboutis
Ms. Adriana (Andi) Karaboutis
Independent Director
Independent Director
27.63K
+22.91%
Mr. Orlando D. Ashford
Mr. Orlando D. Ashford
Independent Chairman of the Board
Independent Chairman of the Board
22.17K
+40.91%
Mr. Jeffrey B. (Jeff) Kindler, Esq.
Mr. Jeffrey B. (Jeff) Kindler, Esq.
Independent Director
Independent Director
10.56K
+95.21%
Ms. Julia M. Brown
Ms. Julia M. Brown
Independent Director
Independent Director
8.03K
+178.57%
查看更多
名称
名称/职务
职务
持股
持股变动
Mr. Patrick Lockwood-Taylor
Mr. Patrick Lockwood-Taylor
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
85.81K
+5.48%
Mr. Geoffrey M. (Geoff) Parker
Mr. Geoffrey M. (Geoff) Parker
Independent Director
Independent Director
60.29K
+16.75%
Mr. Eduardo Guarita Bezerra
Mr. Eduardo Guarita Bezerra
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
48.95K
+6.53%
Mr. Robert Willis
Mr. Robert Willis
Chief Human Resources Officer, Executive Vice President
Chief Human Resources Officer, Executive Vice President
41.94K
+3.68%
Mr. Bradley A. (Brad) Alford
Mr. Bradley A. (Brad) Alford
Independent Director
Independent Director
41.16K
+14.30%
Mr. Donal O'Connor
Mr. Donal O'Connor
Independent Director
Independent Director
31.84K
+19.30%
收入明细
单位: USD更新时间: 10月6日 周一
单位: USD更新时间: 10月6日 周一
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
业务USD
名称
营收
占比
Skincare and personal hygiene
180.70M
17.11%
Upper respiratory
178.70M
16.92%
Pain and sleep-aids
143.70M
13.60%
Healthy lifestyle
134.40M
12.72%
Digestive health
119.60M
11.32%
其他
299.20M
28.33%
地区USD
名称
营收
占比
United States
610.90M
57.83%
Europe
421.70M
39.92%
All other countries
23.70M
2.24%
业务
地区
业务USD
名称
营收
占比
Skincare and personal hygiene
180.70M
17.11%
Upper respiratory
178.70M
16.92%
Pain and sleep-aids
143.70M
13.60%
Healthy lifestyle
134.40M
12.72%
Digestive health
119.60M
11.32%
其他
299.20M
28.33%
股东统计
更新时间: 8月16日 周六
更新时间: 8月16日 周六
持股股东
股东类型
持股股东
持股股东
占比
T. Rowe Price Associates, Inc.
10.49%
The Vanguard Group, Inc.
10.15%
BlackRock Institutional Trust Company, N.A.
8.55%
Dimensional Fund Advisors, L.P.
5.46%
State Street Global Advisors (US)
5.34%
其他
60.02%
持股股东
持股股东
占比
T. Rowe Price Associates, Inc.
10.49%
The Vanguard Group, Inc.
10.15%
BlackRock Institutional Trust Company, N.A.
8.55%
Dimensional Fund Advisors, L.P.
5.46%
State Street Global Advisors (US)
5.34%
其他
60.02%
股东类型
持股股东
占比
Investment Advisor
61.46%
Investment Advisor/Hedge Fund
33.51%
Hedge Fund
5.68%
Research Firm
1.96%
Pension Fund
1.49%
Sovereign Wealth Fund
1.05%
Bank and Trust
0.64%
Individual Investor
0.45%
Family Office
0.05%
机构持股
更新时间: 10月1日 周三
更新时间: 10月1日 周三
报告期
机构数
持股数
持股占比
持股变动
2025Q3
759
145.63M
105.85%
-23.73M
2025Q2
791
145.85M
106.01%
-21.49M
2025Q1
812
142.34M
103.61%
-25.15M
2024Q4
806
140.28M
102.80%
-22.73M
2024Q3
798
138.34M
101.41%
-20.68M
2024Q2
800
136.29M
99.93%
-16.34M
2024Q1
799
135.97M
99.77%
-20.56M
2023Q4
809
135.31M
99.86%
-23.17M
2023Q3
797
133.80M
98.82%
-17.47M
2023Q2
837
137.28M
101.45%
-14.92M
查看更多
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
T. Rowe Price Associates, Inc.
14.43M
10.49%
+143.89K
+1.01%
Jun 30, 2025
The Vanguard Group, Inc.
13.96M
10.15%
+58.03K
+0.42%
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
11.76M
8.55%
-46.83K
-0.40%
Jun 30, 2025
Dimensional Fund Advisors, L.P.
7.51M
5.46%
+377.67K
+5.29%
Jun 30, 2025
State Street Global Advisors (US)
7.34M
5.34%
+637.68K
+9.51%
Jun 30, 2025
DePrince, Race & Zollo, Inc.
4.56M
3.32%
-7.61K
-0.17%
Jun 30, 2025
Ion Asset Management Israel Ltd
3.82M
2.77%
+983.73K
+34.71%
Jun 30, 2025
Neuberger Berman, LLC
3.71M
2.7%
-88.92K
-2.34%
Jun 30, 2025
Cooke & Bieler, L.P.
3.30M
2.4%
-241.34K
-6.82%
Jun 30, 2025
Sound Shore Management, Inc.
3.29M
2.39%
+2.50K
+0.08%
Jun 30, 2025
查看更多
持股ETF
更新时间: 10月6日 周一
更新时间: 10月6日 周一
机构名称
占比
Sound Equity Dividend Income ETF
3.77%
SPDR S&P Pharmaceuticals ETF
2.85%
AAM Bahl & Gaynor Small/Mid Cap Income Growth ETF
2.76%
Direxion Daily Pharmaceutical & Medical Bl 3X ETF
2.08%
Invesco Pharmaceuticals ETF
2.06%
ProShares S&P MidCap 400 Dividend Aristocrats ETF
1.59%
iShares U.S. Pharmaceuticals ETF
1.52%
Invesco High Yield Equity Dividend Achievers ETF
1.4%
Cultivar ETF
1.3%
Invesco S&P MidCap 400 Pure Value ETF
1.3%
查看更多
Sound Equity Dividend Income ETF
占比3.77%
SPDR S&P Pharmaceuticals ETF
占比2.85%
AAM Bahl & Gaynor Small/Mid Cap Income Growth ETF
占比2.76%
Direxion Daily Pharmaceutical & Medical Bl 3X ETF
占比2.08%
Invesco Pharmaceuticals ETF
占比2.06%
ProShares S&P MidCap 400 Dividend Aristocrats ETF
占比1.59%
iShares U.S. Pharmaceuticals ETF
占比1.52%
Invesco High Yield Equity Dividend Achievers ETF
占比1.4%
Cultivar ETF
占比1.3%
Invesco S&P MidCap 400 Pure Value ETF
占比1.3%
分红派息
近5年累计派现
698.10M
美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
Feb 19, 2025
PRGO.NB Interim Cash Dividend of gross USD 0.29 paid on Mar 25, 2025 going ex on Mar 07, 2025
Mar 07, 2025
Mar 25, 2025
Mar 07, 2025
Nov 01, 2024
PRGO.NB Final Cash Dividend of gross USD 0.276 paid on Dec 17, 2024 going ex on Nov 29, 2024
Nov 29, 2024
Dec 17, 2024
Nov 29, 2024
Aug 01, 2024
PRGO.NB Interim Cash Dividend of gross USD 0.276 paid on Sep 17, 2024 going ex on Aug 30, 2024
Aug 30, 2024
Sep 17, 2024
Aug 30, 2024
May 01, 2024
PRGO.NB Interim Cash Dividend of gross USD 0.276 paid on Jun 18, 2024 going ex on May 31, 2024
May 31, 2024
Jun 18, 2024
May 31, 2024
Feb 26, 2024
PRGO.NB Interim Cash Dividend of gross USD 1.1 paid on Mar 26, 2024 going ex on Mar 07, 2024
Mar 08, 2024
Mar 26, 2024
Mar 07, 2024
Nov 03, 2023
PRGO.NB Final Cash Dividend of gross USD 0.273 paid on Dec 19, 2023 going ex on Nov 30, 2023
Dec 01, 2023
Dec 19, 2023
Nov 30, 2023
Aug 02, 2023
PRGO.NB Interim Cash Dividend of gross USD 0.273 paid on Sep 19, 2023 going ex on Aug 31, 2023
Sep 01, 2023
Sep 19, 2023
Aug 31, 2023
May 04, 2023
PRGO.NB Interim Cash Dividend of gross USD 0.273 paid on Jun 20, 2023 going ex on Jun 01, 2023
Jun 02, 2023
Jun 20, 2023
Jun 01, 2023
Feb 21, 2023
PRGO.NB Interim Cash Dividend of gross USD 0.273 paid on Mar 28, 2023 going ex on Mar 09, 2023
Mar 10, 2023
Mar 28, 2023
Mar 09, 2023
Nov 04, 2022
PRGO.NB Final Cash Dividend of gross USD 0.26 paid on Dec 20, 2022 going ex on Dec 01, 2022
Dec 02, 2022
Dec 20, 2022
Dec 01, 2022
查看更多
拆合股
公告日期
类型
比率
暂无数据
公告日期
类型
比率
暂无数据
